## CBRE: CBRE Group Inc - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($152.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. How Executive Moves and Property Deals at CBRE Group (CBRE) Have Changed Its Investment Story**
- Source: Sahm | 20251130T220734 | Bullish | Relevance: 98%
-  CBRE Group has recently made key executive appointments and facilitated significant property sales, including multifamily and retail assets, reinforcing its leadership in real estate transactions. These developments highlight institutional confidence in CBRE's capabilities and suggest ongoing positive momentum in commercial property markets, influencing its future investment narrative. Despite this, investors should remain aware of potential market volatility and economic cycles that could impact the company.

**2. Camden Copper Square Apartments in Phoenix sell for $77M**
- Source: KTAR News 92.3 FM | 20251201T050000 | Neutral | Relevance: 75%
- The 332-unit Camden Copper Square Apartments in downtown Phoenix were sold for $77 million to ColRich, a San Diego-based real estate firm. The seller was Camden Property Trust, and the transaction was announced on November 20. The complex features various amenities, including two parking structures, swimming pools, coworking spaces, a fitness center, and a dog park.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Barclays | $190 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.2%)
- Blackrock Inc.: 9.3% (-1.2%)
- State Street Corpora: 4.7% (+0.8%)
- Principal Financial : 3.2% (+9.3%)
- FMR, LLC: 2.8% (+89.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.6B |
| Beta | 1.34 |
| 52W Range | $108.45 - $171.00 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 21.7 |
| Current P/E | 25.1 |
| YoY Growth | 16.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.8% to -1.1% (-4.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.98), confirming momentum. RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.15% (CS: 52) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | 0.98 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 1.114x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $159.33
- **Stop Loss:** $152.11 (4.5% risk)
- **Target:** $166.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 69
- **Position Value:** $10,993.77
- **Portfolio %:** 10.99%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-12 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.46 | $1.61 | +10.6% |
| 2025Q2 | $1.07 | $1.19 | +11.2% |
| 2025Q1 | $0.76 | $0.86 | +12.7% |
| 2024Q4 | $2.23 | $2.32 | +3.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*